Back

Preclinical evaluation of a novel dual acting V1a/V2 vasopressin receptor antagonist by using a noninvasive cardiac output monitor

27 May 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Basic Science - Chronic Heart Failure – Pathophysiology and Mechanisms Experimental Heart Failure HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Thomas Mondritzki

Bayer AG, Wuppertal (Germany)

46 More presentations in this session

Presentation thumbnail
Professor H. Sabbah (Detroit, US)
Abstract Slides
Presentation thumbnail
Mr M. Lichy (Bratislava, SK)
Abstract
Presentation thumbnail
Doctor M. Gawor (Warsaw, PL)
Abstract
Presentation thumbnail
Doctor M. Vanderheyden (Aalst, BE)
Abstract
Presentation thumbnail
Mr J. Berg (Lund, SE)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Basic Science - Chronic Heart Failure – Pathophysiology and Mechanisms

The Event

Event poster

Heart Failure 2018

27 May 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Vasopressors
12 May 2024
thumbnail
Congress Presentation
Non-invasive hemodynamic measurement using whole-body impedance cardiography in patients hospitalized due to congestive heart failure: an effective alternative to invasive right heart catheterization?
18 May 2025
thumbnail
Congress Presentation
Efficacy and safety of various doses of the new dual endothelin receptor antagonist aprocitentan in the treatment of hypertension
31 August 2019
thumbnail
Congress Presentation
Effects of the glucagon like peptide-1 receptor analogue, sodium-glucose co-transporter 2 and their combination on myocardial work index and vascular function in diabetes after 3-month treatment
3 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources